nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—Thalidomide—leprosy	0.195	0.361	CbGbCtD
Capecitabine—CYP2C9—Rifampicin—leprosy	0.189	0.35	CbGbCtD
Capecitabine—CYP2C9—Dapsone—leprosy	0.156	0.289	CbGbCtD
Capecitabine—Peroneal nerve palsy—Thalidomide—leprosy	0.015	0.0339	CcSEcCtD
Capecitabine—Localized exfoliation—Dapsone—leprosy	0.0148	0.0333	CcSEcCtD
Capecitabine—Mood alteration NOS—Thalidomide—leprosy	0.0101	0.0229	CcSEcCtD
Capecitabine—Bronchopneumonia—Thalidomide—leprosy	0.00932	0.021	CcSEcCtD
Capecitabine—TYMS—Menadione—Thalidomide—leprosy	0.00899	1	CbGdCrCtD
Capecitabine—Swelling face—Dapsone—leprosy	0.00835	0.0188	CcSEcCtD
Capecitabine—Lymphoedema—Thalidomide—leprosy	0.00833	0.0188	CcSEcCtD
Capecitabine—Gastrointestinal perforation—Thalidomide—leprosy	0.0078	0.0176	CcSEcCtD
Capecitabine—Thromboembolic event—Thalidomide—leprosy	0.00755	0.0171	CcSEcCtD
Capecitabine—Peripheral sensory neuropathy—Thalidomide—leprosy	0.00712	0.0161	CcSEcCtD
Capecitabine—Polyneuropathy—Thalidomide—leprosy	0.00624	0.0141	CcSEcCtD
Capecitabine—Rales—Thalidomide—leprosy	0.00496	0.0112	CcSEcCtD
Capecitabine—Dysaesthesia—Thalidomide—leprosy	0.0047	0.0106	CcSEcCtD
Capecitabine—Proteinuria—Dapsone—leprosy	0.00452	0.0102	CcSEcCtD
Capecitabine—Ascites—Thalidomide—leprosy	0.00448	0.0101	CcSEcCtD
Capecitabine—Protein urine present—Dapsone—leprosy	0.00446	0.0101	CcSEcCtD
Capecitabine—Altered state of consciousness—Thalidomide—leprosy	0.00441	0.00995	CcSEcCtD
Capecitabine—Paraesthesia oral—Thalidomide—leprosy	0.00434	0.00979	CcSEcCtD
Capecitabine—Transient ischaemic attack—Thalidomide—leprosy	0.00403	0.0091	CcSEcCtD
Capecitabine—Lymphopenia—Thalidomide—leprosy	0.00398	0.00897	CcSEcCtD
Capecitabine—Skin exfoliation—Dapsone—leprosy	0.00379	0.00856	CcSEcCtD
Capecitabine—Venous thrombosis—Thalidomide—leprosy	0.00377	0.00851	CcSEcCtD
Capecitabine—Gastric ulcer—Thalidomide—leprosy	0.0035	0.0079	CcSEcCtD
Capecitabine—Platelet count decreased—Thalidomide—leprosy	0.00342	0.00772	CcSEcCtD
Capecitabine—Febrile neutropenia—Thalidomide—leprosy	0.00338	0.00763	CcSEcCtD
Capecitabine—Deep vein thrombosis—Thalidomide—leprosy	0.00334	0.00755	CcSEcCtD
Capecitabine—Serum creatinine increased—Thalidomide—leprosy	0.00331	0.00747	CcSEcCtD
Capecitabine—Hypomagnesaemia—Thalidomide—leprosy	0.0032	0.00723	CcSEcCtD
Capecitabine—Oral candidiasis—Thalidomide—leprosy	0.0032	0.00723	CcSEcCtD
Capecitabine—Hypothyroidism—Thalidomide—leprosy	0.00317	0.00715	CcSEcCtD
Capecitabine—Embolism—Thalidomide—leprosy	0.00317	0.00715	CcSEcCtD
Capecitabine—Nail disorder—Thalidomide—leprosy	0.00314	0.00708	CcSEcCtD
Capecitabine—Intestinal obstruction—Thalidomide—leprosy	0.00299	0.00674	CcSEcCtD
Capecitabine—Hypercalcaemia—Thalidomide—leprosy	0.00293	0.00661	CcSEcCtD
Capecitabine—Neuralgia—Thalidomide—leprosy	0.00293	0.00661	CcSEcCtD
Capecitabine—Thrombosis—Thalidomide—leprosy	0.00287	0.00649	CcSEcCtD
Capecitabine—Hepatomegaly—Thalidomide—leprosy	0.00287	0.00649	CcSEcCtD
Capecitabine—Metrorrhagia—Thalidomide—leprosy	0.00285	0.00643	CcSEcCtD
Capecitabine—Pleural effusion—Thalidomide—leprosy	0.00266	0.006	CcSEcCtD
Capecitabine—Skin ulcer—Thalidomide—leprosy	0.00261	0.0059	CcSEcCtD
Capecitabine—Hyperaesthesia—Thalidomide—leprosy	0.00259	0.00585	CcSEcCtD
Capecitabine—Nasopharyngitis—Dapsone—leprosy	0.00258	0.00582	CcSEcCtD
Capecitabine—Muscular weakness—Dapsone—leprosy	0.00254	0.00574	CcSEcCtD
Capecitabine—Tingling sensation—Thalidomide—leprosy	0.00253	0.00571	CcSEcCtD
Capecitabine—Myocardial ischaemia—Thalidomide—leprosy	0.00253	0.00571	CcSEcCtD
Capecitabine—Influenza—Dapsone—leprosy	0.00249	0.00563	CcSEcCtD
Capecitabine—Petechiae—Thalidomide—leprosy	0.00247	0.00558	CcSEcCtD
Capecitabine—Proteinuria—Thalidomide—leprosy	0.00232	0.00523	CcSEcCtD
Capecitabine—Protein urine present—Thalidomide—leprosy	0.00228	0.00515	CcSEcCtD
Capecitabine—Photosensitivity reaction—Dapsone—leprosy	0.00228	0.00514	CcSEcCtD
Capecitabine—Musculoskeletal stiffness—Thalidomide—leprosy	0.00227	0.00512	CcSEcCtD
Capecitabine—Skin discolouration—Thalidomide—leprosy	0.00225	0.00508	CcSEcCtD
Capecitabine—Cellulitis—Thalidomide—leprosy	0.00224	0.00505	CcSEcCtD
Capecitabine—Hyperbilirubinaemia—Thalidomide—leprosy	0.00224	0.00505	CcSEcCtD
Capecitabine—Hypocalcaemia—Thalidomide—leprosy	0.00222	0.00502	CcSEcCtD
Capecitabine—Herpes simplex—Thalidomide—leprosy	0.00221	0.00498	CcSEcCtD
Capecitabine—Neuropathy peripheral—Dapsone—leprosy	0.00218	0.00492	CcSEcCtD
Capecitabine—Hearing impaired—Thalidomide—leprosy	0.00214	0.00482	CcSEcCtD
Capecitabine—Bone pain—Thalidomide—leprosy	0.00212	0.00479	CcSEcCtD
Capecitabine—Gait disturbance—Thalidomide—leprosy	0.00208	0.00471	CcSEcCtD
Capecitabine—Coordination abnormal—Thalidomide—leprosy	0.00207	0.00468	CcSEcCtD
Capecitabine—Neck pain—Thalidomide—leprosy	0.00206	0.00465	CcSEcCtD
Capecitabine—Phosphatase alkaline increased—Thalidomide—leprosy	0.00203	0.00459	CcSEcCtD
Capecitabine—Pulmonary embolism—Thalidomide—leprosy	0.00203	0.00459	CcSEcCtD
Capecitabine—Pharyngitis—Dapsone—leprosy	0.00198	0.00447	CcSEcCtD
Capecitabine—Depressed level of consciousness—Thalidomide—leprosy	0.00196	0.00443	CcSEcCtD
Capecitabine—Colitis—Thalidomide—leprosy	0.00195	0.00441	CcSEcCtD
Capecitabine—Skin exfoliation—Thalidomide—leprosy	0.00194	0.00438	CcSEcCtD
Capecitabine—Candida infection—Thalidomide—leprosy	0.00194	0.00438	CcSEcCtD
Capecitabine—Neuropathy—Thalidomide—leprosy	0.00191	0.00431	CcSEcCtD
Capecitabine—Dry eye—Thalidomide—leprosy	0.00188	0.00424	CcSEcCtD
Capecitabine—Tinnitus—Dapsone—leprosy	0.00186	0.0042	CcSEcCtD
Capecitabine—Oesophagitis—Thalidomide—leprosy	0.00186	0.0042	CcSEcCtD
Capecitabine—Mental disability—Thalidomide—leprosy	0.00177	0.00399	CcSEcCtD
Capecitabine—Sepsis—Thalidomide—leprosy	0.00177	0.00399	CcSEcCtD
Capecitabine—Erythema—Dapsone—leprosy	0.00174	0.00392	CcSEcCtD
Capecitabine—Thrombophlebitis—Thalidomide—leprosy	0.00171	0.00385	CcSEcCtD
Capecitabine—Diabetes mellitus—Thalidomide—leprosy	0.0017	0.00383	CcSEcCtD
Capecitabine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.0017	0.00383	CcSEcCtD
Capecitabine—Photosensitivity—Thalidomide—leprosy	0.00168	0.0038	CcSEcCtD
Capecitabine—Gastroenteritis—Thalidomide—leprosy	0.00167	0.00376	CcSEcCtD
Capecitabine—Vascular purpura—Thalidomide—leprosy	0.00165	0.00373	CcSEcCtD
Capecitabine—Deafness—Thalidomide—leprosy	0.00165	0.00373	CcSEcCtD
Capecitabine—Vision blurred—Dapsone—leprosy	0.00164	0.0037	CcSEcCtD
Capecitabine—Eye pain—Thalidomide—leprosy	0.00164	0.00369	CcSEcCtD
Capecitabine—Renal failure acute—Thalidomide—leprosy	0.0016	0.00361	CcSEcCtD
Capecitabine—Libido decreased—Thalidomide—leprosy	0.00159	0.00359	CcSEcCtD
Capecitabine—Amnesia—Thalidomide—leprosy	0.00157	0.00355	CcSEcCtD
Capecitabine—Increased appetite—Thalidomide—leprosy	0.00157	0.00355	CcSEcCtD
Capecitabine—Dermatitis exfoliative—Thalidomide—leprosy	0.00157	0.00353	CcSEcCtD
Capecitabine—Vertigo—Dapsone—leprosy	0.00156	0.00352	CcSEcCtD
Capecitabine—Atrial fibrillation—Thalidomide—leprosy	0.00156	0.00352	CcSEcCtD
Capecitabine—TYMP—blood vessel—leprosy	0.00156	0.192	CbGeAlD
Capecitabine—Dermatitis bullous—Thalidomide—leprosy	0.00155	0.00349	CcSEcCtD
Capecitabine—Purpura—Thalidomide—leprosy	0.00153	0.00346	CcSEcCtD
Capecitabine—Arthritis—Thalidomide—leprosy	0.00152	0.00343	CcSEcCtD
Capecitabine—Cough—Dapsone—leprosy	0.00152	0.00342	CcSEcCtD
Capecitabine—Cardiac failure—Thalidomide—leprosy	0.00151	0.00342	CcSEcCtD
Capecitabine—Cerebrovascular accident—Thalidomide—leprosy	0.00151	0.0034	CcSEcCtD
Capecitabine—Lethargy—Thalidomide—leprosy	0.00151	0.0034	CcSEcCtD
Capecitabine—Hyponatraemia—Thalidomide—leprosy	0.00148	0.00335	CcSEcCtD
Capecitabine—Osteoarthritis—Thalidomide—leprosy	0.00148	0.00333	CcSEcCtD
Capecitabine—Pain in extremity—Thalidomide—leprosy	0.00148	0.00333	CcSEcCtD
Capecitabine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00148	0.00333	CcSEcCtD
Capecitabine—Diplopia—Thalidomide—leprosy	0.00148	0.00333	CcSEcCtD
Capecitabine—Disturbance in sexual arousal—Thalidomide—leprosy	0.00147	0.00331	CcSEcCtD
Capecitabine—Migraine—Thalidomide—leprosy	0.00145	0.00328	CcSEcCtD
Capecitabine—Face oedema—Thalidomide—leprosy	0.00143	0.00322	CcSEcCtD
Capecitabine—Cardiac arrest—Thalidomide—leprosy	0.0014	0.00317	CcSEcCtD
Capecitabine—Mood swings—Thalidomide—leprosy	0.0014	0.00316	CcSEcCtD
Capecitabine—Ataxia—Thalidomide—leprosy	0.00139	0.00313	CcSEcCtD
Capecitabine—Tachycardia—Dapsone—leprosy	0.00138	0.00312	CcSEcCtD
Capecitabine—Blood creatinine increased—Thalidomide—leprosy	0.00138	0.00312	CcSEcCtD
Capecitabine—Dehydration—Thalidomide—leprosy	0.00137	0.0031	CcSEcCtD
Capecitabine—Liver function test abnormal—Thalidomide—leprosy	0.00136	0.00308	CcSEcCtD
Capecitabine—Dry skin—Thalidomide—leprosy	0.00135	0.00306	CcSEcCtD
Capecitabine—Orthostatic hypotension—Thalidomide—leprosy	0.00135	0.00304	CcSEcCtD
Capecitabine—Hypokalaemia—Thalidomide—leprosy	0.00134	0.00303	CcSEcCtD
Capecitabine—Breast disorder—Thalidomide—leprosy	0.00133	0.00301	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00133	0.003	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00133	0.003	CcSEcCtD
Capecitabine—Muscular weakness—Thalidomide—leprosy	0.0013	0.00294	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Thalidomide—leprosy	0.0013	0.00294	CcSEcCtD
Capecitabine—Abdominal distension—Thalidomide—leprosy	0.00129	0.0029	CcSEcCtD
Capecitabine—Insomnia—Dapsone—leprosy	0.00128	0.00289	CcSEcCtD
Capecitabine—Dysphagia—Thalidomide—leprosy	0.00128	0.00288	CcSEcCtD
Capecitabine—Influenza—Thalidomide—leprosy	0.00128	0.00288	CcSEcCtD
Capecitabine—Bronchospasm—Thalidomide—leprosy	0.00126	0.00283	CcSEcCtD
Capecitabine—Angina pectoris—Thalidomide—leprosy	0.00124	0.00281	CcSEcCtD
Capecitabine—Bronchitis—Thalidomide—leprosy	0.00123	0.00277	CcSEcCtD
Capecitabine—Pancytopenia—Thalidomide—leprosy	0.00121	0.00274	CcSEcCtD
Capecitabine—Neutropenia—Thalidomide—leprosy	0.00119	0.00269	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Thalidomide—leprosy	0.00119	0.00268	CcSEcCtD
Capecitabine—Photosensitivity reaction—Thalidomide—leprosy	0.00117	0.00263	CcSEcCtD
Capecitabine—Weight increased—Thalidomide—leprosy	0.00116	0.00262	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dapsone—leprosy	0.00116	0.00262	CcSEcCtD
Capecitabine—Weight decreased—Thalidomide—leprosy	0.00115	0.00261	CcSEcCtD
Capecitabine—Hyperglycaemia—Thalidomide—leprosy	0.00115	0.0026	CcSEcCtD
Capecitabine—Pneumonia—Thalidomide—leprosy	0.00114	0.00258	CcSEcCtD
Capecitabine—Infestation NOS—Thalidomide—leprosy	0.00114	0.00257	CcSEcCtD
Capecitabine—Infestation—Thalidomide—leprosy	0.00114	0.00257	CcSEcCtD
Capecitabine—Depression—Thalidomide—leprosy	0.00113	0.00256	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00113	0.00255	CcSEcCtD
Capecitabine—Acute coronary syndrome—Thalidomide—leprosy	0.00112	0.00253	CcSEcCtD
Capecitabine—Abdominal pain—Dapsone—leprosy	0.00112	0.00253	CcSEcCtD
Capecitabine—Body temperature increased—Dapsone—leprosy	0.00112	0.00253	CcSEcCtD
Capecitabine—Renal failure—Thalidomide—leprosy	0.00112	0.00253	CcSEcCtD
Capecitabine—Neuropathy peripheral—Thalidomide—leprosy	0.00112	0.00252	CcSEcCtD
Capecitabine—Myocardial infarction—Thalidomide—leprosy	0.00112	0.00252	CcSEcCtD
Capecitabine—Stomatitis—Thalidomide—leprosy	0.00111	0.0025	CcSEcCtD
Capecitabine—Conjunctivitis—Thalidomide—leprosy	0.00111	0.0025	CcSEcCtD
Capecitabine—Haematuria—Thalidomide—leprosy	0.00109	0.00245	CcSEcCtD
Capecitabine—Epistaxis—Thalidomide—leprosy	0.00107	0.00242	CcSEcCtD
Capecitabine—Agranulocytosis—Thalidomide—leprosy	0.00106	0.0024	CcSEcCtD
Capecitabine—Bradycardia—Thalidomide—leprosy	0.00104	0.00235	CcSEcCtD
Capecitabine—Rhinitis—Thalidomide—leprosy	0.00102	0.00231	CcSEcCtD
Capecitabine—Hepatitis—Thalidomide—leprosy	0.00102	0.00231	CcSEcCtD
Capecitabine—Hypoaesthesia—Thalidomide—leprosy	0.00102	0.00229	CcSEcCtD
Capecitabine—Pharyngitis—Thalidomide—leprosy	0.00101	0.00229	CcSEcCtD
Capecitabine—Urinary tract disorder—Thalidomide—leprosy	0.00101	0.00228	CcSEcCtD
Capecitabine—Oedema peripheral—Thalidomide—leprosy	0.00101	0.00227	CcSEcCtD
Capecitabine—Urethral disorder—Thalidomide—leprosy	0.001	0.00226	CcSEcCtD
Capecitabine—Visual impairment—Thalidomide—leprosy	0.000985	0.00222	CcSEcCtD
Capecitabine—Erythema multiforme—Thalidomide—leprosy	0.000966	0.00218	CcSEcCtD
Capecitabine—Eye disorder—Thalidomide—leprosy	0.000955	0.00216	CcSEcCtD
Capecitabine—Tinnitus—Thalidomide—leprosy	0.000953	0.00215	CcSEcCtD
Capecitabine—Cardiac disorder—Thalidomide—leprosy	0.000948	0.00214	CcSEcCtD
Capecitabine—Angiopathy—Thalidomide—leprosy	0.000927	0.00209	CcSEcCtD
Capecitabine—Immune system disorder—Thalidomide—leprosy	0.000923	0.00208	CcSEcCtD
Capecitabine—Mediastinal disorder—Thalidomide—leprosy	0.000921	0.00208	CcSEcCtD
Capecitabine—Chills—Thalidomide—leprosy	0.000917	0.00207	CcSEcCtD
Capecitabine—Arrhythmia—Thalidomide—leprosy	0.000913	0.00206	CcSEcCtD
Capecitabine—CDA—tendon—leprosy	0.00091	0.113	CbGeAlD
Capecitabine—Alopecia—Thalidomide—leprosy	0.000903	0.00204	CcSEcCtD
Capecitabine—Vomiting—Dapsone—leprosy	0.000902	0.00204	CcSEcCtD
Capecitabine—Mental disorder—Thalidomide—leprosy	0.000895	0.00202	CcSEcCtD
Capecitabine—Malnutrition—Thalidomide—leprosy	0.000889	0.00201	CcSEcCtD
Capecitabine—Headache—Dapsone—leprosy	0.000888	0.00201	CcSEcCtD
Capecitabine—Flatulence—Thalidomide—leprosy	0.000876	0.00198	CcSEcCtD
Capecitabine—Dysgeusia—Thalidomide—leprosy	0.000871	0.00197	CcSEcCtD
Capecitabine—Back pain—Thalidomide—leprosy	0.00086	0.00194	CcSEcCtD
Capecitabine—Muscle spasms—Thalidomide—leprosy	0.000855	0.00193	CcSEcCtD
Capecitabine—Nausea—Dapsone—leprosy	0.000842	0.0019	CcSEcCtD
Capecitabine—Vision blurred—Thalidomide—leprosy	0.000838	0.00189	CcSEcCtD
Capecitabine—Tremor—Thalidomide—leprosy	0.000833	0.00188	CcSEcCtD
Capecitabine—Ill-defined disorder—Thalidomide—leprosy	0.000825	0.00186	CcSEcCtD
Capecitabine—Anaemia—Thalidomide—leprosy	0.000822	0.00186	CcSEcCtD
Capecitabine—Malaise—Thalidomide—leprosy	0.000802	0.00181	CcSEcCtD
Capecitabine—Vertigo—Thalidomide—leprosy	0.000799	0.0018	CcSEcCtD
Capecitabine—Syncope—Thalidomide—leprosy	0.000798	0.0018	CcSEcCtD
Capecitabine—Leukopenia—Thalidomide—leprosy	0.000796	0.0018	CcSEcCtD
Capecitabine—Palpitations—Thalidomide—leprosy	0.000786	0.00177	CcSEcCtD
Capecitabine—DPYD—testis—leprosy	0.000783	0.0969	CbGeAlD
Capecitabine—Loss of consciousness—Thalidomide—leprosy	0.000782	0.00176	CcSEcCtD
Capecitabine—Cough—Thalidomide—leprosy	0.000776	0.00175	CcSEcCtD
Capecitabine—Hypertension—Thalidomide—leprosy	0.000768	0.00173	CcSEcCtD
Capecitabine—Chest pain—Thalidomide—leprosy	0.000757	0.00171	CcSEcCtD
Capecitabine—Myalgia—Thalidomide—leprosy	0.000757	0.00171	CcSEcCtD
Capecitabine—Arthralgia—Thalidomide—leprosy	0.000757	0.00171	CcSEcCtD
Capecitabine—Anxiety—Thalidomide—leprosy	0.000755	0.0017	CcSEcCtD
Capecitabine—CDA—testis—leprosy	0.000754	0.0932	CbGeAlD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000752	0.0017	CcSEcCtD
Capecitabine—Discomfort—Thalidomide—leprosy	0.000748	0.00169	CcSEcCtD
Capecitabine—Dry mouth—Thalidomide—leprosy	0.000741	0.00167	CcSEcCtD
Capecitabine—Confusional state—Thalidomide—leprosy	0.000732	0.00165	CcSEcCtD
Capecitabine—Oedema—Thalidomide—leprosy	0.000726	0.00164	CcSEcCtD
Capecitabine—Infection—Thalidomide—leprosy	0.000721	0.00163	CcSEcCtD
Capecitabine—Shock—Thalidomide—leprosy	0.000714	0.00161	CcSEcCtD
Capecitabine—Nervous system disorder—Thalidomide—leprosy	0.000712	0.00161	CcSEcCtD
Capecitabine—Thrombocytopenia—Thalidomide—leprosy	0.000711	0.0016	CcSEcCtD
Capecitabine—Tachycardia—Thalidomide—leprosy	0.000709	0.0016	CcSEcCtD
Capecitabine—Skin disorder—Thalidomide—leprosy	0.000705	0.00159	CcSEcCtD
Capecitabine—Hyperhidrosis—Thalidomide—leprosy	0.000702	0.00158	CcSEcCtD
Capecitabine—Anorexia—Thalidomide—leprosy	0.000692	0.00156	CcSEcCtD
Capecitabine—Hypotension—Thalidomide—leprosy	0.000678	0.00153	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000661	0.00149	CcSEcCtD
Capecitabine—Insomnia—Thalidomide—leprosy	0.000657	0.00148	CcSEcCtD
Capecitabine—Paraesthesia—Thalidomide—leprosy	0.000652	0.00147	CcSEcCtD
Capecitabine—Dyspnoea—Thalidomide—leprosy	0.000647	0.00146	CcSEcCtD
Capecitabine—Dyspepsia—Thalidomide—leprosy	0.000639	0.00144	CcSEcCtD
Capecitabine—Decreased appetite—Thalidomide—leprosy	0.000631	0.00142	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Thalidomide—leprosy	0.000627	0.00141	CcSEcCtD
Capecitabine—Fatigue—Thalidomide—leprosy	0.000626	0.00141	CcSEcCtD
Capecitabine—Pain—Thalidomide—leprosy	0.000621	0.0014	CcSEcCtD
Capecitabine—Constipation—Thalidomide—leprosy	0.000621	0.0014	CcSEcCtD
Capecitabine—TYMS—skin of body—leprosy	0.000618	0.0764	CbGeAlD
Capecitabine—Feeling abnormal—Thalidomide—leprosy	0.000598	0.00135	CcSEcCtD
Capecitabine—Gastrointestinal pain—Thalidomide—leprosy	0.000594	0.00134	CcSEcCtD
Capecitabine—Urticaria—Thalidomide—leprosy	0.000577	0.0013	CcSEcCtD
Capecitabine—Abdominal pain—Thalidomide—leprosy	0.000574	0.0013	CcSEcCtD
Capecitabine—Body temperature increased—Thalidomide—leprosy	0.000574	0.0013	CcSEcCtD
Capecitabine—TYMP—tendon—leprosy	0.000548	0.0678	CbGeAlD
Capecitabine—Hypersensitivity—Thalidomide—leprosy	0.000535	0.00121	CcSEcCtD
Capecitabine—Asthenia—Thalidomide—leprosy	0.000521	0.00118	CcSEcCtD
Capecitabine—Pruritus—Thalidomide—leprosy	0.000514	0.00116	CcSEcCtD
Capecitabine—Diarrhoea—Thalidomide—leprosy	0.000497	0.00112	CcSEcCtD
Capecitabine—Dizziness—Thalidomide—leprosy	0.00048	0.00108	CcSEcCtD
Capecitabine—TYMS—tendon—leprosy	0.00047	0.0582	CbGeAlD
Capecitabine—Vomiting—Thalidomide—leprosy	0.000462	0.00104	CcSEcCtD
Capecitabine—Rash—Thalidomide—leprosy	0.000458	0.00103	CcSEcCtD
Capecitabine—Dermatitis—Thalidomide—leprosy	0.000457	0.00103	CcSEcCtD
Capecitabine—Headache—Thalidomide—leprosy	0.000455	0.00103	CcSEcCtD
Capecitabine—TYMP—testis—leprosy	0.000454	0.0561	CbGeAlD
Capecitabine—TYMP—nervous system—leprosy	0.000445	0.0551	CbGeAlD
Capecitabine—Nausea—Thalidomide—leprosy	0.000431	0.000973	CcSEcCtD
Capecitabine—CES1—testis—leprosy	0.000392	0.0484	CbGeAlD
Capecitabine—TYMS—testis—leprosy	0.000389	0.0482	CbGeAlD
Capecitabine—CES1—nervous system—leprosy	0.000384	0.0475	CbGeAlD
Capecitabine—TYMS—nervous system—leprosy	0.000382	0.0473	CbGeAlD
